Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Home›Companies›Biogen
Biogen logo

Biogen

Cambridge, MA, United States Biotech 7,500 employees Founded 1978 BIIB biogen.com ↗
8 Products & services
18 Licensed medicines
38 Clinical trials
1 Site
7,500 Employees

About Biogen

Biogen is a pioneer in neuroscience headquartered in Cambridge, Massachusetts, developing therapies for neurological and neurodegenerative diseases including multiple sclerosis and Alzheimer's.

Sector
Biotech
Headquarters
Cambridge, MA, United States
Founded
1978
Employees
7,500
Facilities
1 site

Milestones

Milestones as listed on biogen.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

2025
Plans announced for new global HQ in Cambridge, MA
Scheduled to open for the company's 50th anniversary in 2028.
Source: biogen.com
2025
Further $2 billion North Carolina manufacturing investment announced
Announced in July 2025.
Source: biogen.com

Leadership Team

Leadership as listed on sec.gov, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Christopher A. Viehbacher

President, Chief Executive Officer
Source: sec.gov

Robin C. Kramer

Executive Vice President and Chief Financial Officer
Source: sec.gov

Priya Singhal, M.D., M.P.H.

Executive Vice President, Head of Development
Source: sec.gov

Jane Grogan, Ph.D.

Executive Vice President, Head of Research
Source: sec.gov

Rachid Izzar

Executive Vice President, Global Product Strategy and Commercialization
Source: sec.gov

Nicole Murphy

Executive Vice President, Pharmaceutical Operations and Technology
Source: sec.gov

Products & Services

Products and services as listed on biogen-uk-ie.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Medicine

LEQEMBI (lecanemab)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com
Medicine

SPINRAZA (nusinersen sodium)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com
Medicine

TYSABRI (natalizumab)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com
Medicine

VUMERITY (diroximel fumarate)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com
Medicine

QALSODY (tofersen)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com
Medicine

SKYCLARYS (omavoloxelone)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com
Medicine

ZURZUVAE (zuranolone)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com
Medicine

BENEPALI (etanercept)

Listed on Biogen's UK & Ireland medicines page.

Source: biogen-uk-ie.com

Sites in Ireland

Dublin

Office

Biogen Idec (Ireland) Limited office at Magna Business Park.

Source: biogen-uk-ie.com

Sites as listed on biogen-uk-ie.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Pipeline & Regulatory Record

What public registers list for Biogen: clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 22 Nov 2026.

38Trials as lead sponsor
18Recruiting now
4With a site in Ireland
0FDA device clearances

Clinical trials 38 in our ClinicalTrials.gov registers · 3 in the EU register

StudyPhaseStatus
A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia
NCT06953583 · site in Ireland · Friedreich Ataxia
Phase 3Active, closed
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
NCT05658497 · site in Ireland · Multiple Sclerosis
ObservationalRecruiting
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)
NCT07223723 · Amyotrophic Lateral Sclerosis
Phase 4Active, closed
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)
NCT06685757 · Antibody-mediated Rejection
Phase 3Active, closed
A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
NCT06054893 · Friedreich Ataxia
Phase 1Active, closed
A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)
NCT05767736 · Multiple Sclerosis
ObservationalActive, closed
Adult Spinal Muscular Atrophy (SMA) China Registry
NCT05618379 · Muscular Atrophy, Spinal
ObservationalActive, closed
A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec
NCT05575011 · Healthy Volunteer, Muscular Atrophy, Spinal
Phase 1Active, closed
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
NCT05531565 · Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Phase 2/3Active, closed
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
NCT05399888 · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
Phase 2Active, closed

Showing 10 of 38, trials with Irish sites first. The full lists are on the sponsor pages below.

All trials by sponsor name 2 registry names

Drugs in these trials 14 compounds

EU trials register (CTIS) 3 authorised or ongoing · 2 in Ireland

NICE technology appraisals 8 of its medicines · 8 current

Appraisals of medicines sold under a brand this company holds in EMA or FDA records, from our NICE appraisals register. NICE decisions apply to the NHS in England. © NICE 2026 technology appraisal guidance. Available from www.nice.org.uk/guidance. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

Group (Biogen): founded 1978, headquarters Cambridge, website biogen.com. Wikidata Q864338 · Wikipedia. From Wikidata (CC0), matched by the group's SEC filer number.

How this is matched: register records are linked to this page by the organisation name they carry, here Biogen; Biogen Idec Research Limited; Biogen Netherlands B.V.; BIOGEN IDEC; BIOGEN; Biogen Netherlands B.V.  and 2 more. Spot a wrong match? Tell us.

Financials & Irish Entities

From the annual reports Biogen Inc. files with the US Securities and Exchange Commission (10-K, US GAAP), in USD as reported. Latest financial year: to Dec 2025.

$9.9bnRevenue
$1.8bnR&D expense
18.0%R&D as % of revenue
$1.3bnNet income (13.1% margin)
Revenue and R&D expense, USD bn$0.0bn$5.0bn$10bn$15bnDec 2021Dec 2022Dec 2023Dec 2024Dec 2025Dec 2021: $11bn (Revenue)Dec 2022: $10bn (Revenue)Dec 2023: $9.8bn (Revenue)Dec 2024: $9.7bn (Revenue)Dec 2025: $9.9bn (Revenue)RevenueDec 2021: $2.5bn (R&D expense)Dec 2022: $2.2bn (R&D expense)Dec 2023: $2.5bn (R&D expense)Dec 2024: $2.0bn (R&D expense)Dec 2025: $1.8bn (R&D expense)R&D expense
RevenueR&D expense
Year toRevenueR&DR&D %Net incomeFiling
Dec 2025$9.89bn$1.78bn18.0%$1.29bn10-K 2026
Dec 2024$9.68bn$1.98bn20.5%$1.63bn10-K 2026
Dec 2023$9.84bn$2.45bn24.9%$1.16bn10-K 2026
Dec 2022$10.17bn$2.23bn21.9%$3.05bn10-K 2025
Dec 2021$10.98bn$2.50bn22.8%$1.56bn10-K 2024

R&D is shown as tagged in the filing, which for this company can exclude acquired in-process R&D. Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.

Companies registered in Ireland 2 active in the CRO register

CompanyCRO no.RegisteredLast accounts
Biogen Idec (Ireland) Limited
LTD - Private Company Limited by Shares
4217182006Dec 2025
Biogen Distribution Services Limited
LTD - Private Company Limited by Shares
6890622021Dec 2025

From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Biogen Inc. as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.

In the News

No coverage yet — our newsroom tracks Biogen continuously.

Research Publications

EUROPE PMC · LIVE
Searching Europe PMC for affiliated publications...

FDA Recalls (US)

OPENFDA · LIVE
Checking openFDA drug-recall records...